Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Nuvalent, Inc. amended Amendment No. 1 to the Sales Agreement with Cowen valued at $135.0 million (effective 2022-10-31).
- Action
- amendment
- Agreement
- atm program
- Counterparty
- Cowen
- Value
- $135.0 million
- Effective
- 2022-10-31
Exact text from the filing
On October 31, 2022, prior to the Company’s entry into the Underwriting Agreement, the Company and Cowen entered into an Amendment No. 1 to the Sales Agreement, dated as of August 10, 2022, between the Company and Cowen (the “Sales Agreement Amendment”) pursuant to which the Company may offer and sell shares of Common Stock from time to time through Cowen in an “at the market offering” (the “ATM Facility”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Nuvalent, Inc. entered into Underwriting Agreement with J.P. Morgan Securities LLC, Cowen and Company, LLC, Piper Sandler & Co. and BMO Capital Markets Corp. (effective 2022-10-31).
- Action
- entry
- Agreement
- underwriting
- Counterparty
- J.P. Morgan Securities LLC, Cowen and Company, LLC, Piper Sandler & Co. and BMO Capital Markets Corp.
- Effective
- 2022-10-31
Exact text from the filing
On October 31, 2022, Nuvalent, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC, Cowen and Company, LLC (“Cowen”), Piper Sandler & Co. and BMO Capital Markets Corp., as representatives of the several underwriters (the “Underwriters”), relating to an underwritten public offering (the “Offering”) of 6,865,672 shares (the “Shares”) of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”).
View on SEC.gov